Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Theravance Biopharma, Inc.

TBPH

Valuace

Růst

Zdraví

Cena

$ 16.41

-0.10 (-0.50%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Total Revenues	107.5	107.5	64.4	57.4	51.3	55.3	71.9	73.4	60.4	15.4	48.6	42.1	11.7	0.2	130.1
Cost of Revenues	5.5	5.5	0.0	40.6	0.0	0.0	0.0	0.0	0.7	6.0	2.9	4.7	4.1	0.0	0.0
Gross Profit	101.9	101.9	64.4	16.8	51.3	55.3	71.9	73.4	59.7	9.4	45.8	37.5	7.6	0.2	130.1

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	45.9	20.0	26.2	15.4	18.8	16.9	14.3	14.5	17.6	15.7
Cost of Revenues	-24.5	8.1	10.5	11.5	0.0	9.3	10.0	9.0	4.3	1.3
Gross Profit	70.4	11.9	15.7	3.9	18.8	7.6	4.3	5.5	13.2	14.4

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
R&D Expenses	0.0	0.0	0.0	40.6	63.4	193.7	261.0	219.2	201.3	173.9	141.7	129.2	168.5	120.6	114.0
Selling General & Admin Expenses	0.0	0.0	0.0	70.1	67.1	99.3	108.7	106.1	97.1	95.6	84.5	90.2	71.6	35.9	25.7
Depreciation & Amortization	2.7	5.5	3.6	6.1	21.4	125.2	71.3	42.1	3.2	4.0	3.1	3.0	2.7	2.7	3.3
Total Operating Expenses	115.2	115.2	111.3	113.5	130.5	293.0	369.6	325.3	298.4	269.5	226.2	219.4	240.2	156.5	139.7
Operating Income	-13.2	-13.2	-46.9	-56.0	-92.0	-257.8	-297.8	-251.9	-238.8	-260.1	-180.5	-181.9	-232.5	-156.3	-9.6

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	8.3
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	16.1
Depreciation & Amortization	1.5	0.4	0.4	0.4	0.7	0.4	0.4	0.4	1.7	1.3
Total Operating Expenses	60.1	18.3	18.4	18.4	28.0	18.4	20.0	16.7	23.8	24.5
Operating Income	10.4	-6.5	-2.7	-14.4	-9.2	-10.8	-15.7	-11.2	-6.2	-8.8

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Interest Income	2.4	0.0	4.9	9.1	8.5	1.1	2.8	8.4	12.0	5.0	1.3	0.6	1.9	0.0	0.0
Interest Expense	2.5	2.5	2.5	2.4	6.4	46.9	44.6	31.9	10.5	8.5	1.4	0.0	0.0	0.0	0.0
Other Expense	142.5	142.5	2.3	6.8	-0.9	58.2	11.2	10.2	11.2	-8.0	-0.1	0.6	1.9	0.0	0.0
IBT	129.2	129.2	-44.6	-49.3	-92.8	-199.6	-286.5	-241.7	-226.1	-271.7	-180.6	-181.3	-230.7	-156.3	-9.6
Income Tax Expense	23.4	23.4	11.8	5.9	0.0	-0.2	-8.5	-5.2	-10.6	13.7	10.1	1.0	6.4	0.0	0.0
Net Income	105.9	105.9	-56.4	-55.2	-92.8	-199.4	-278.0	-236.5	-215.5	-285.4	-190.7	-182.2	-237.0	-156.3	-9.6

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	0.0	0.0	1.5	0.9	0.9	1.4	1.1	1.4	1.8	1.8
Interest Expense	0.6	0.6	0.7	0.6	0.6	0.6	0.6	0.6	0.6	0.6
Other Expense	62.7	3.6	75.9	0.3	0.3	0.8	0.5	0.8	1.2	1.2
IBT	73.1	-2.9	73.2	-14.1	-8.9	-10.1	-15.2	-10.4	-5.0	-7.6
Income Tax Expense	12.0	-6.5	18.4	-0.6	6.6	2.6	1.3	1.3	3.5	1.4
Net Income	61.0	3.6	54.8	-13.6	-15.5	-12.7	-16.5	-11.7	-8.5	-9.0

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
EPS	$0.00	$0.00	$0.00	$-1.00	$-1.26	$-2.87	$-4.46	$-4.25	$-3.99	$-5.45	$-4.26	$-5.34	$-7.46	$-4.84	$-0.30
EPS Diluted	$0.00	$0.00	$0.00	$-1.00	$-1.26	$-2.87	$-4.46	$-4.25	$-3.99	$-5.45	$-4.26	$-5.34	$-7.46	$-4.84	$-0.30
Shares Outstanding	50.9	50.3	48.8	55.3	73.6	69.5	62.3	55.6	54.0	52.4	44.7	34.2	31.8	32.3	32.3
Diluted Shares Outstanding	53.1	51.5	48.8	55.3	73.6	69.5	62.3	55.6	54.0	52.4	44.7	34.2	31.8	32.3	32.3

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.17	$-0.17
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.17	$-0.17
Shares Outstanding	50.9	50.5	50.2	49.7	49.3	49.0	48.7	48.3	49.4	52.4
Diluted Shares Outstanding	53.1	51.9	50.7	49.7	49.3	49.0	48.7	48.3	49.4	52.4

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash And Equivalents	46.3	37.8	39.5	298.2	90.0	81.5	58.1	378.0	89.0	344.7	112.7	89.2	0.0
Short Term Investments	49.7	50.6	62.9	29.3	83.5	211.5	222.8	127.3	259.6	156.4	59.7	165.4	0.0
Total Cash & ST Investments	96.1	88.4	102.4	327.5	173.5	292.9	280.8	505.3	348.6	501.1	172.4	306.0	0.0
Accounts Receivable	14.3	68.4	17.5	16.8	57.6	69.7	50.6	10.1	7.1	9.1	37.2	2.1	1.1
Inventory	0.0	0.0	0.0	1.5	10.2	20.4	0.0	0.0	16.8	12.2	10.0	12.5	10.4
Other Current Assets	8.9	4.3	13.6	7.7	8.6	10.4	7.1	17.5	6.0	3.1	5.1	8.2	2.6
Total Current Assets	119.3	161.1	133.5	353.5	249.9	393.3	338.5	532.8	378.7	528.5	237.5	326.8	14.1

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	329.7	281.9	110.6	37.8	23.4	46.3	53.8	39.5	71.7	-42.5
Short Term Investments	0.0	56.9	20.2	50.6	68.0	49.7	46.1	62.9	62.3	210.0
Total Cash & ST Investments	329.7	338.8	130.9	88.4	91.4	96.1	100.0	102.4	134.0	167.5
Accounts Receivable	18.3	21.9	15.4	68.4	16.8	14.3	14.7	17.5	17.1	15.8
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.0
Other Current Assets	6.8	5.6	4.1	4.3	8.3	8.9	9.7	13.6	10.6	8.8
Total Current Assets	354.7	366.3	150.3	161.1	116.5	119.3	124.3	133.5	161.7	192.0

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Property, Plant & Equipment	40.0	35.8	45.4	52.0	53.3	59.7	59.2	13.2	10.2	8.5	9.9	9.7	10.2
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.8	0.0	0.0	0.0	67.5	12.8	5.0	11.9	41.6	91.6	50.9	51.4	0.0
Other Long-Term Assets	201.9	157.3	203.1	201.9	4.1	3.3	6.1	2.4	10.9	10.7	1.9	-50.1	0.8
Total Long-Term Assets	242.7	193.1	248.5	253.9	124.9	75.7	70.3	27.4	62.7	110.8	62.6	11.0	11.1
Total Assets	362.0	354.2	382.0	607.4	374.8	469.1	408.8	560.2	441.4	639.3	300.1	337.8	25.2

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	31.7	33.1	34.5	35.8	37.1	40.0	44.1	45.4	46.9	48.0
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8
Other Long-Term Assets	26.0	26.6	158.9	157.3	202.5	202.8	202.9	202.3	204.2	205.8
Total Long-Term Assets	60.8	59.7	193.3	193.1	239.6	242.7	247.0	248.5	251.9	254.6
Total Assets	415.5	426.0	343.6	354.2	356.1	362.0	371.3	382.0	413.6	446.6

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Accounts Payable	1.7	2.2	1.5	1.6	3.1	6.8	4.8	9.0	5.9	1.7	18.8	9.9	6.9
Short-Term Debt	4.2	10.7	7.8	28.7	17.4	29.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	22.9	13.3	15.4	-1.6	37.9	76.1	57.8	46.1	56.5	47.4	30.5	31.2	21.7
Current Liabilities	22.9	32.1	24.8	28.7	58.6	123.6	111.7	98.6	62.6	49.3	49.5	41.3	36.9

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	0.0	1.7	2.4	2.2	1.5	1.7	1.7	1.5	2.4	1.6
Short-Term Debt	0.0	10.9	10.8	10.7	4.2	4.2	4.1	7.8	19.4	18.3
Other Current Liabilities	37.4	15.4	12.4	13.3	17.8	17.1	15.9	15.4	0.5	3.9
Current Liabilities	37.4	54.6	31.5	32.1	23.4	22.9	21.7	24.8	25.4	24.5

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Long-Term Debt	42.4	39.1	45.2	45.4	652.1	647.1	492.9	454.4	223.7	222.7	0.0	0.0	0.0
Capital Leases	42.4	49.8	49.2	74.1	52.7	47.2	47.7	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	69.0	0.0	0.0	0.0	-0.3	-0.3	-6.8	-26.2	0.0	0.0	0.0	0.0	0.0
Total Liabilities	168.3	178.6	169.0	165.6	713.4	772.8	632.7	611.8	326.2	289.0	57.1	48.0	42.2

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	33.7	35.6	37.3	39.1	40.8	42.4	43.8	90.5	82.2	85.0
Capital Leases	33.7	46.5	48.2	49.8	45.0	46.7	47.9	45.2	41.1	42.5
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.4	-0.2	-0.2
Total Liabilities	182.8	201.2	177.6	178.6	170.5	168.3	166.4	169.0	167.5	166.5

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Common Stock	193.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-937.3	-965.5	-909.1	-853.9	-1,726.0	-1,526.6	-1,248.6	-1,012.1	-797.7	-512.2	-321.6	-139.3	-17.0
Comprehensive Income	0.0	0.0	-0.1	0.0	0.0	0.0	0.1	-0.2	-0.7	-0.3	-0.1	-0.1	0.0
Total Common Equity	193.7	175.5	213.0	441.8	-338.6	-303.8	-223.8	-51.6	115.2	350.2	243.1	289.8	-17.0

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	232.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	0.0	-924.3	-979.1	-965.5	-950.0	-937.3	-920.8	-909.1	-900.6	-891.6
Comprehensive Income	0.0	0.0	0.0	0.0	0.1	0.0	0.0	-0.1	-0.2	-0.3
Total Common Equity	232.7	224.8	166.0	175.5	185.7	193.7	204.9	213.0	246.1	280.2

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total Debt		46.7	49.8	49.2	74.1	652.1	647.1	492.9	454.4	223.7	222.7	0.0	0.0	0.0
Book Value		193.7	175.5	213.0	441.8	-338.6	-303.8	-223.8	-51.6	115.2	350.2	243.1	289.8	-17.0

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		232.7	224.8	166.0	175.5	185.7	193.7	204.9	213.0	246.1	280.2

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Income	-45.7	105.9	-56.4	-55.2	-92.8	-199.4	-278.0	-236.5	-215.5	-285.4	-190.7	-182.2	-237.0	-156.3	-9.6
Depreciation & Amortization	5.4	5.6	3.6	4.3	7.0	9.7	9.1	6.2	3.2	4.0	3.1	3.0	2.7	2.7	3.3
Stock-Based Compensation	22.7	18.5	21.4	25.4	39.7	62.1	63.0	60.5	51.3	49.1	41.2	54.1	43.2	22.5	21.3
Change Working Capital	2.1	120.5	20.4	-8.3	42.4	-39.6	-39.5	-45.4	59.4	22.4	46.9	-37.8	12.8	10.2	-134.3
Change In Accounts Receivable	1.5	-27.1	-1.0	0.0	-2.7	1.8	6.1	-11.3	1.6	-1.6	1.3	-1.6	-0.1	-0.2	-2.7
Change In Accounts Payable	0.1	0.3	0.8	0.0	-1.6	-3.5	3.7	-4.3	3.6	3.8	-16.4	8.7	3.9	2.1	-1.5
Change In Inventories	-3.5	0.0	0.0	0.0	0.0	-26.4	-22.5	1.4	-1.6	-7.3	-3.2	1.0	-6.6	-3.1	-4.8
Other Non-cash Items	19.3	-0.4	7.1	3.7	-183.3	3.9	-20.4	-23.0	0.0	0.0	0.2	-8.1	3.2	0.0	0.2
Cash from Operations	-8.8	0.0	0.0	-27.0	-187.0	-207.9	-250.4	-238.2	-112.9	-201.1	-99.0	-168.9	-175.2	-121.0	-119.1

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	61.0	3.6	54.8	-13.6	-15.5	-12.7	-16.5	-11.7	-8.5	-9.0
Depreciation & Amortization	0.4	0.6	0.9	1.1	0.7	0.8	1.0	1.2	1.4	0.9
Stock-Based Compensation	4.5	4.6	4.5	4.9	5.8	5.0	5.4	5.2	5.8	6.3
Change Working Capital	261.7	-16.9	157.8	51.9	13.9	-0.3	2.7	4.1	-3.4	-1.3
Change In Accounts Receivable	99.6	3.7	-6.6	53.1	-1.6	-2.5	0.4	2.8	-0.4	-1.3
Change In Accounts Payable	0.4	0.5	-0.7	0.2	0.8	-0.2	0.0	0.2	-0.3	0.3
Change In Inventories	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-4.8	1.3
Other Non-cash Items	-333.7	0.6	0.7	0.6	0.8	2.0	3.6	0.6	1.9	0.6
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.9	-2.5

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Capital Expenditure	-0.8	0.0	-0.3	-2.5	-0.6	-3.4	-6.6	-3.2	-7.2	-2.4	-2.1	-2.6	-3.1	-2.7	-2.6
Acquisitions	-1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	-58.1	-248.2	-143.0	-134.5	-103.1	-158.3	-402.0	-423.9	-183.3	-288.8	-237.6	-73.0	-168.9	0.0	0.0
Sales of Investment	72.3	143.0	155.7	102.8	158.0	286.2	419.3	339.0	347.2	234.9	91.5	186.7	66.4	0.0	0.0
Other Investing Activities	18.6	0.0	0.0	1.5	1,099.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	-0.7	0.1	0.2
Cash from Investing	13.3	0.0	0.0	-32.7	1,154.0	124.5	10.7	-83.1	176.7	-56.3	-148.2	111.0	-106.3	-2.6	-2.4

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023
Capital Expenditure	0.0	0.0	0.0	0.0	-0.2	0.0	0.0	-0.1	-0.7
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.5
Investments	-64.9	-124.7	-56.6	-2.0	-40.0	-44.9	-31.2	-26.9	0.0
Sales of Investment	65.5	24.5	20.4	32.6	55.9	27.5	28.2	44.0	0.0
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.7

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Debt Repaid	0.0	0.0	0.0	0.0	-631.6	-10.7	-246.8	-2.2	0.0	0.0	0.0	0.0	0.0	0.0	-0.1
Debt Issued	4.1	49.8	0.7	-25.0	53.7	15.7	401.0	40.7	230.6	1.1	222.7	0.0	0.0	0.0	0.1
Issuance of Common Stock	0.7	0.0	0.0	0.0	0.0	108.2	139.9	3.5	0.0	0.0	253.0	79.0	0.0	0.0	0.0
Repurchase of Common Stock	-64.4	-4.0	-3.1	-199.6	-132.3	-9.1	-9.7	-3.2	-9.8	-8.6	-3.9	-0.8	-0.2	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	-385.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	-1.8	0.0	0.0	0.6	5.1	3.5	764.8	3.1	235.0	10.2	230.1	3.0	370.8	123.6	121.6
Cash from Financing	-63.8	0.0	0.0	-198.9	-758.8	91.9	263.1	1.3	225.2	1.7	479.2	81.3	370.6	123.6	121.5

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	33.7	-12.8	-1.7	-1.7	4.8	-1.7	-1.2	2.7	4.1	-1.4
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock	-2.0	-0.7	-0.5	-0.9	-0.5	-0.4	-0.5	-1.7	-30.8	-31.4
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-30.6	-31.4

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Change in Cash		-59.3	130.0	-1.7	-258.6	208.2	8.5	23.4	-320.0	289.0	-255.7	232.0	23.5	370.6	0.0	0.0
Closing Cash Balance		46.3	168.6	38.6	40.4	299.0	90.8	82.3	58.9	378.9	89.0	344.7	112.7	89.2	0.0	0.0

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-7.0	-107.2	171.3	72.8	14.4	-23.0	-7.5	14.3	-32.1	-33.9
Closing Cash Balance		168.6	174.8	282.8	111.5	38.6	24.2	47.2	54.7	40.4	72.5

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Free Cash Flow		-9.6	238.5	-11.9	-29.5	-187.6	-211.3	-257.0	-241.4	-120.1	-203.5	-101.1	-171.5	-178.3	-123.7	-121.7
Real Free Cash Flow		-32.3	220.0	-33.3	-54.9	-227.3	-273.3	-320.0	-301.8	-171.4	-252.6	-142.3	-225.6	-221.5	-146.2	-143.0

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-6.1	-6.5	208.0	43.0	-1.1	-5.2	-4.5	-1.1	-1.5	-2.5
Real Free Cash Flow		-10.6	-11.1	203.5	38.2	-6.9	-10.2	-9.8	-6.3	-7.4	-8.8